Targeted HFpEF therapy based on matchmaking of human and animal models

Arantxa Barandiaran Aizpurua; Blanche Schroen; Marc van Bilsen; Vanessa van Empel

doi:10.1152/ajpheart.00024.2018

Targeted HFpEF therapy based on matchmaking of human and animal models

Arantxa Barandiaran Aizpurua, Blanche Schroen, Marc van Bilsen, Vanessa van Empel^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	H1670-H1683
Number of pages	14
Journal	American Journal of Physiology-heart and Circulatory Physiology
Volume	315
Issue number	6
DOIs	https://doi.org/10.1152/ajpheart.00024.2018
Publication status	Published - Dec 2018

Keywords

heart failure with preserved ejection fraction
inflammation
personalized medicine
translational research
trial design
PRESERVED EJECTION FRACTION
CHRONIC HEART-FAILURE
LEFT-VENTRICULAR FUNCTION
C-REACTIVE PROTEIN
DIASTOLIC DYSFUNCTION
CARDIAC FIBROSIS
ANGIOTENSIN-II
ENDOTHELIAL DYSFUNCTION
MYOCARDIAL DYSFUNCTION
CHRONIC INHIBITION

Access to Document

10.1152/ajpheart.00024.2018

Cite this

Aizpurua, A. B., Schroen, B., van Bilsen, M., & van Empel, V. (2018). Targeted HFpEF therapy based on matchmaking of human and animal models. American Journal of Physiology-heart and Circulatory Physiology, 315(6), H1670-H1683. https://doi.org/10.1152/ajpheart.00024.2018

@article{b707c2ca6ccb469a8b88417f9cd43937,

title = "Targeted HFpEF therapy based on matchmaking of human and animal models",

keywords = "heart failure with preserved ejection fraction, inflammation, personalized medicine, translational research, trial design, PRESERVED EJECTION FRACTION, CHRONIC HEART-FAILURE, LEFT-VENTRICULAR FUNCTION, C-REACTIVE PROTEIN, DIASTOLIC DYSFUNCTION, CARDIAC FIBROSIS, ANGIOTENSIN-II, ENDOTHELIAL DYSFUNCTION, MYOCARDIAL DYSFUNCTION, CHRONIC INHIBITION",

author = "Aizpurua, {Arantxa Barandiaran} and Blanche Schroen and {van Bilsen}, Marc and {van Empel}, Vanessa",

year = "2018",

month = dec,

doi = "10.1152/ajpheart.00024.2018",

language = "English",

volume = "315",

pages = "H1670--H1683",

journal = "American Journal of Physiology-heart and Circulatory Physiology",

issn = "0363-6135",

publisher = "American Physiological Society",

number = "6",

}

TY - JOUR

T1 - Targeted HFpEF therapy based on matchmaking of human and animal models

AU - Aizpurua, Arantxa Barandiaran

AU - Schroen, Blanche

AU - van Bilsen, Marc

AU - van Empel, Vanessa

PY - 2018/12

Y1 - 2018/12

KW - heart failure with preserved ejection fraction

KW - inflammation

KW - personalized medicine

KW - translational research

KW - trial design

KW - PRESERVED EJECTION FRACTION

KW - CHRONIC HEART-FAILURE

KW - LEFT-VENTRICULAR FUNCTION

KW - C-REACTIVE PROTEIN

KW - DIASTOLIC DYSFUNCTION

KW - CARDIAC FIBROSIS

KW - ANGIOTENSIN-II

KW - ENDOTHELIAL DYSFUNCTION

KW - MYOCARDIAL DYSFUNCTION

KW - CHRONIC INHIBITION

U2 - 10.1152/ajpheart.00024.2018

DO - 10.1152/ajpheart.00024.2018

M3 - Review article

VL - 315

SP - H1670-H1683

JO - American Journal of Physiology-heart and Circulatory Physiology

JF - American Journal of Physiology-heart and Circulatory Physiology

SN - 0363-6135

IS - 6

ER -